R

Active Director Director DIN 07157403
DIN 07157403 First appointment Apr 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value •••• Premium profile

About Rajendran

Data last updated:

Rajendran is a Director at Prs Pharmaceuticals Private Limited (since 2015). The company operates in Pharma. Prs Pharmaceuticals Private Limited reported revenue of ₹7.16 Cr (FY 2019).

DIN 07157403
Primary Designation Director
Industry Pharma
First Appointment 21 Apr 2015
Oldest Company Age 22 yrs
Largest company Prs Pharmaceuticals Private Limited · ₹7.16 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prs Pharmaceuticals Private Limited U24231TZ2004PTC011374
Director21 Apr 20152004₹7.16 Cr (FY 2019)Active

Board colleagues of Rajendran

NameDINCompanyDesignation
Rajamanickam05270219Prs Pharmaceuticals Private LimitedManaging Director
Sekar Raji02632205Prs Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Prs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendran

Rajendran currently holds 1 directorship: Prs Pharmaceuticals Private Limited (Director, since 21 Apr 2015, revenue ₹7.16 Cr (FY 2019)).

Rajendran was first appointed on 21 Apr 2015 as Director at Prs Pharmaceuticals Private Limited.

The current boards of Rajendran's companies include Rajamanickam (Prs Pharmaceuticals Private Limited), Sekar Raji (Prs Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available